CN470 is a BET/CBP/p300 multi-bromodomain inhibitor and has an anti-tumor activity against MLL-rearranged acute lymphoblastic leukemia
Natsuki Imayoshi, Makoto Yoshioka, Kuniaki Tanaka, Shyh‐Ming Yang, Koshi Akahane, Yuki Toda, Shigekuni Hosogi, Takeshi Inukai, Seiji Okada, David J. Maloney, Tatsutoshi Nakahata, Junko Takita, Itaru Kato, Eishi Ashihara
Topics & Concepts
BromodomainBRD4Cancer researchBET inhibitorIn vivoLeukemiaCell cycleBiologyMolecular biologyAcetylationApoptosisChemistryGeneImmunologyBiochemistryGeneticsProtein Degradation and InhibitorsMultiple Myeloma Research and TreatmentsUbiquitin and proteasome pathways